CRDO insider notice: $21.26M proposed sale of 154,984 Class A shares
Rhea-AI Filing Summary
Credo Technology Group Holding Ltd reported a Form 144 notice for a proposed sale of 154,984 Class A common shares, scheduled approximately on 10/07/2025, listed for sale through Goldman Sachs & Co. LLC on the NASD. The filing shows those shares were acquired in tranches between 01/27/2022 and 04/04/2024, primarily as restricted stock units and a private issuance from the issuer. The filing also discloses multiple prior sales by related parties in 08/2025 and 09/2025 with individual gross proceeds reported per sale.
Positive
- Transparent disclosure of acquisition dates and nature (RSUs and private issuance)
- Broker and exchange identified (Goldman Sachs & Co. LLC; NASD), aiding execution traceability
- Prior sales reported with gross proceeds, showing historical disposition activity
Negative
- Large proposed sale of 154,984 shares with aggregate market value $21,263,804.80 may increase float pressure
- Multiple recent related-party sales in 08/2025 and 09/2025 with combined gross proceeds approximately $33,685,055, indicating substantial insider liquidity
- Approximate sale date (10/07/2025) is not definitive and requires follow-up to confirm execution
Insights
TL;DR: Significant insider selling disclosed; sequence of prior sales shows active dispositions by related parties.
The filing documents a proposed sale of 154,984 Class A shares through Goldman Sachs with an aggregate market value listed as $21,263,804.80 and an approximate sale date of 10/07/2025. The shares were acquired in multiple tranches between 01/27/2022 and 04/04/2024, primarily as restricted stock units and a private issuer issuance.
Related-party activity includes several cash sales in 08/2025 and 09/2025 with reported gross proceeds per transaction. Monitor additional Form 4/Form 144 filings and the actual execution of the 10/07/2025 sale to confirm timing, sizes, and any remaining lock-up constraints.
TL;DR: Filing appears to meet Rule 144 disclosure items by listing acquisition history and recent sales.
The notice supplies acquisition dates, transaction nature (issuer issuance and RSUs), number of shares acquired per tranche, and broker details, aligning with Rule 144 disclosure elements required for proposed sales. The signer represents no undisclosed material adverse information as part of the certification language.
Watch for matching Form 4 reports and any statements that would clarify whether sales are part of a trading plan (Rule 10b5-1). Confirm whether the listed approximate sale date 10/07/2025 is executed as planned.
FAQ
What does the Form 144 filed by Credo Technology (CRDO) disclose?
When were the shares to be sold originally acquired?
Have related parties sold Credo (CRDO) shares recently?
Who is the broker handling the proposed sale?
Does the Form 144 state whether a trading plan under Rule 10b5-1 is being used?
What should investors monitor after this filing?